Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Income from Non-Controlling Interests (2016 - 2026)

Lexaria Bioscience's Income from Non-Controlling Interests history spans 11 years, with the latest figure at -$2753.0 for Q1 2026.

  • Quarterly results put Income from Non-Controlling Interests at -$2753.0 for Q1 2026, up 26.78% from a year ago — trailing twelve months through Feb 2026 was -$8153.0 (up 26.48% YoY), and the annual figure for FY2025 was -$9593.0, up 27.92%.
  • Income from Non-Controlling Interests for Q1 2026 was -$2753.0 at Lexaria Bioscience, down from -$2496.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$1390.0 in Q3 2025 to a low of -$45696.0 in Q3 2022.
  • The 5-year median for Income from Non-Controlling Interests is -$3760.0 (2025), against an average of -$10575.4.
  • The sharpest move saw Income from Non-Controlling Interests plummeted 270.62% in 2022, then skyrocketed 81.63% in 2024.
  • Year by year, Income from Non-Controlling Interests stood at -$13362.0 in 2022, then surged by 57.23% to -$5715.0 in 2023, then skyrocketed by 48.75% to -$2929.0 in 2024, then grew by 14.78% to -$2496.0 in 2025, then decreased by 10.3% to -$2753.0 in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at -$2753.0, -$2496.0, and -$1390.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.